Eastman Chemical — Jul 30, 2026 release
Fiscal 2026 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915389-26-000138
Showing in the filing
Capital expenditures
“approximately $400 million”
Period
FY2026
Measure
Company-defined measure
Source
Prose
All guidance in this release · 12
Working capital for FY2026
“expect to release working capital in the second half of 2026”
Cost reduction, net of inflation for FY2026
“between $125 million and $150 million”
Reduce costs, net of inflation
“between $125 million and $150 million”
Capital expenditures for FY2026
“approximately $400 million”
Earnings growth vs. prior year for FY2026
“significantly improve earnings in 2026 versus 2025”
Operating cash flow for FY2026
“approach $900 million”
Advanced Materials EBIT (sequential) for Q3 FY2026
“expect EBIT to be higher”
Fibers earnings (sequential) for Q3 FY2026
“expect higher earnings in Fibers”
Additives & Functional Products earnings (se… for Q3 FY2026
“expected to decline modestly”
Chemical Intermediates earnings (sequential) for Q3 FY2026
“expected to modestly decline”
Adjusted diluted EPS for Q3 FY2026
“approach second-quarter 2026 EPS of $1.97”
Adjusted EPS for Q3 FY2026
“approach second-quarter 2026 EPS of $1.97”
Exhibit 99.1 · the passage around this item
… earlier in the release
In our Chemical Intermediates segment, we have benefited from significant spread expansion due to the impact on supply chains of the Middle East conflict and substantially more volume to sell this year. We also remain on track to reduce costs between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year. When putting all of these factors together, we remain confident we can significantly improve earnings in 2026 versus 2025. On cash, the inflationary environment is putting pressure on accounts receivable. As a result, we now expect operating cash flow to approach $900 million, which is modestly below our previous expectation of approaching 2025 levels. "Looking specifically at the sequential third-quarter 2026 outlook, we start with Advanced Materials, where we expect EBIT to be higher driven by improved price-cost and improved asset utilization. We also expect higher earnings in Fibers as acetate tow volume increases, with customers increasing purchases to meet their annual contracts. Additives & Functional Products earnings are expected to decline modestly due to seasonally lower volume, particularly in the agriculture market. Chemical Intermediates earnings are expected to modestly decline as the impact of supply chain disruptions lessens. When putting these factors together, we project third-quarter adjusted EPS to approach second-quarter 2026 EPS of $1.97." The third-quarter 2026 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items.
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.